E

Emergent Biosolutions
D

EBS

9.88500
USD
-0.10
(-0.95%)
مغلق
حجم التداول
23,145
الربح لكل سهم
2
العائد الربحي
-
P/E
-3
حجم السوق
535,610,679
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    CBOE
    CBOE
    -0.250
    (-0.13%)
    194.000 USD
    CME
    CME
    0.450
    (0.19%)
    232.740 USD
    G
    GNK
    0.125
    (0.88%)
    14.385 USD
    H
    HAL
    0.650
    (2.22%)
    29.915 USD
    ICE
    ICE
    -1.120
    (-0.75%)
    149.110 USD
    NDAQ
    NDAQ
    0.460
    (0.59%)
    78.840 USD
    N
    NG
    -0.00500
    (-0.15%)
    3.28500 USD
    O
    OFG
    0.960
    (2.22%)
    44.250 USD
    المزيد
الأخبار
المقالات

العنوان: Emergent Biosolutions

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.